Then, the developed PBPK-PD model was further used to simulate plasma concentrations (Figure 5C) and IPA (Figure 5D) of CLOP-AM after 300 mg loading dose followed by 75 mg maintenance dose to CAD patients with DM involving CYP2C19 phenotypes. This evidence concerns the gene CYP2C19 and coronary artery disorder.